Bacillus clausii Enterogermina
Selected indexed studies
- Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. (Adv Ther, 2022) [PMID:36018495]
- Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina(®), and insights into its probiotic properties. (BMC Microbiol, 2019) [PMID:31888501]
- Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores. (BMC Microbiol, 2022) [PMID:36114449]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. (2022) pubmed
- Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina(®), and insights into its probiotic properties. (2019) pubmed
- Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores. (2022) pubmed
- Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy. (2001) pubmed
- Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan. (2016) pubmed
- Evaluating the Compositional Quality of Probiotics Containing Bacillus clausii in India. (2025) pubmed
- Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial. (2020) pubmed
- In vitro and in vivo evaluation of Bacillus clausii against Schistosoma mansoni. (2022) pubmed
- Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii. (2006) pubmed
- Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India. (2022) pubmed